Myomo
15 hedge funds and large institutions have $1.48M invested in Myomo in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 7 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
3.39% more ownership
Funds ownership: 13.15% → 16.54% (+3.4%)
15% less capital invested
Capital invested by funds: $1.73M → $1.48M (-$250K)
25% less funds holding
Funds holding: 20 → 15 (-5)
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Top Buyers
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$82K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$42.5K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$25.6K |
| 4 |
Bank of New York Mellon
New York
|
-$17.1K |
| 5 |
HF
HRT Financial
New York
|
-$16K |
MYO Hedge Fund Activity: Q2 2023 in Review
15 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Myomo (MYO) for Q2 2023, worth a combined $1.48M — down 15% from $1.73M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of MYO and 2 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Worth Venture Partners, adding an estimated $485K. The largest seller was Virtu Financial, exiting entirely with an estimated $82K sold.
- 15 institutional investors held Myomo (MYO) as of Q2 2023, down from 20 in Q1 2023.
- Funds reported $1.48M of Myomo stock for Q2 2023, down 15% quarter-over-quarter.
- 2 funds opened new Myomo positions in Q2 2023 and 7 closed out, a net change of -5 holders.
- The largest Myomo buyer in Q2 2023 was Worth Venture Partners, an estimated $485K added.
- The largest Myomo seller in Q2 2023 was Virtu Financial, an estimated $82K sold.
Based on aggregated 13F filings for Q2 2023.